This registration study assessed clinical outcomes of TQ-B3525, the dual
phosphatidylinositol-3-kinase (PI3K) α/δ inhibitor, in relapsed and/or refractory follicular …

Lymphoma is a form of cancer that impacts the lymphatic system, which plays a crucial role
in defending the body against infections and illnesses. It is characterized by the atypical …

Simple Summary Follicular lymphoma (FL)—a common, indolent, and usually non-curable B-
cell non-Hodgkin lymphoma—is frequently treated with cytotoxic chemotherapy with anti …

Follicular lymphoma (FL), the most common indolent lymphoma, is a clinically and
genetically heterogeneous disease. However, the prognostic value of driver gene mutations …

Follicular lymphoma (FL), the most common indolent non-Hodgkin lymphoma, constitutes a
paradigm of immune tumor microenvironment (TME) contribution to disease onset …

Chromosomal rearrangements have been shown to alter genome organization,
consequently having an impact on gene expression. Studies on certain types of leukemia …

Background Follicular lymphoma (FL), a common indolent B-cell lymphoma, has the
potential to transform into an aggressive lymphoma, such as diffuse large B-cell lymphoma …

Simple Summary Epicardial adipose tissue radio intensity and myocardial extracellular
volume in computed tomography were investigated and evaluated at disease onset and …

The maturation of B cells is a complex, multi-step process. During B cell differentiation,
errors can occur, leading to the emergence of aberrant versions of B cells that, finally …

Background mTORC1 (mechanistic target of rapamycin complex 1) is associated with
lymphoma progression. Oncogenic RRAGC (Rag guanosine triphosphatase C) mutations …